A former sales executive at Insys Therapeutics who is seeking a new trial after a racketeering conviction has cited new evidence that he said shows his ex-lawyers at Weil, Gotshal & Manges kept him in the dark about potential conflicts posed by its simultaneous bankruptcy work for Insys.

Richard Simon was one of five defendants convicted for pushing doctors to prescribe Subsys, a super-potent and addictive painkiller. In his bid for a new trial in Boston federal court, he has argued that Weil could not represent him while working for Insys because the pharmaceutical company’s bankruptcy plans were inextricably linked to its cooperation with prosecutors, who were seeking a huge fine from the company.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]